N-Aryl-prolyl-dipeptides as potent antagonists of VLA-4
摘要:
The design, synthesis, and biological evaluation of N-arylprolyl-dipeptide derivatives as small molecule VLA-4 antagonists is described. Potency against VLA-4 and alpha(4)beta(7) and rat pharmacokinetic evaluation revealed some advantages over the related N-(arylsulfonyl)-prolyl-dipeptide analogues. (C) 2002 Elsevier Science Ltd. All rights reserved.
HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS
申请人:Berger Richard
公开号:US20110028461A1
公开(公告)日:2011-02-03
The present invention provides compounds of Formula I, pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Macrocyclic prolinyl acyl guanidines as inhibitors of β-secretase (BACE)
作者:Kenneth M. Boy、Jason M. Guernon、Yong-Jin Wu、Yunhui Zhang、Joe Shi、Weixu Zhai、Shirong Zhu、Samuel W. Gerritz、Jeremy H. Toyn、Jere E. Meredith、Donna M. Barten、Catherine R. Burton、Charles F. Albright、Andrew C. Good、James E. Grace、Kimberley A. Lentz、Richard E. Olson、John E. Macor、Lorin A. Thompson
DOI:10.1016/j.bmcl.2015.10.031
日期:2015.11
The synthesis, evaluation, and structure-activity relationships of a class of acyl guanidines which inhibit the BACE-1 enzyme are presented. The prolinyl acyl guanidine chemotype (7c), unlike compounds of the parent isothiazole chemotype (1), yielded compounds with good agreement between their enzymatic and cellular potency as well as a reduced susceptibility to P-gp efflux. Further improvements in
N-Aryl-prolyl-dipeptides as potent antagonists of VLA-4
作者:Theodore M. Kamenecka、Thomas Lanza, Jr.、Stephen E. de Laszlo、Bing Li、Ermengilda D. McCauley、Gail Van Riper、Linda A. Egger、Usha Kidambi、Richard A. Mumford、Sharon Tong、Malcolm MacCoss、John A. Schmidt、William K. Hagmann
DOI:10.1016/s0960-894x(02)00356-6
日期:2002.8
The design, synthesis, and biological evaluation of N-arylprolyl-dipeptide derivatives as small molecule VLA-4 antagonists is described. Potency against VLA-4 and alpha(4)beta(7) and rat pharmacokinetic evaluation revealed some advantages over the related N-(arylsulfonyl)-prolyl-dipeptide analogues. (C) 2002 Elsevier Science Ltd. All rights reserved.